G Gambardella, G Viscido, B Tumaini… - Nature …, 2022 - econpapers.repec.org
Cancer cells within a tumour have heterogeneous phenotypes and exhibit dynamic plasticity. How to evaluate such heterogeneity and its impact on outcome and drug response …
G Gambardella, G Viscido, B Tumaini… - Nature …, 2022 - europepmc.org
Cancer cells within a tumour have heterogeneous phenotypes and exhibit dynamic plasticity. How to evaluate such heterogeneity and its impact on outcome and drug response …
G Gambardella, G Viscido, B Tumaini… - Nature …, 2022 - ncbi.nlm.nih.gov
Cancer cells within a tumour have heterogeneous phenotypes and exhibit dynamic plasticity. How to evaluate such heterogeneity and its impact on outcome and drug response …
G Gambardella, G Viscido, B Tumaini… - Nature …, 2022 - ideas.repec.org
Cancer cells within a tumour have heterogeneous phenotypes and exhibit dynamic plasticity. How to evaluate such heterogeneity and its impact on outcome and drug response …
G Gambardella, G Viscido, B Tumaini… - Nature …, 2022 - search.ebscohost.com
Cancer cells within a tumour have heterogeneous phenotypes and exhibit dynamic plasticity. How to evaluate such heterogeneity and its impact on outcome and drug response …
G Gambardella, G Viscido, B Tumaini… - Nature …, 2022 - ui.adsabs.harvard.edu
Cancer cells within a tumour have heterogeneous phenotypes and exhibit dynamic plasticity. How to evaluate such heterogeneity and its impact on outcome and drug response …
G Gambardella, G Viscido, B Tumaini… - Nature …, 2022 - pubmed.ncbi.nlm.nih.gov
Cancer cells within a tumour have heterogeneous phenotypes and exhibit dynamic plasticity. How to evaluate such heterogeneity and its impact on outcome and drug response …
G Gambardella, G Viscido, B Tumaini, A Isacchi… - iris.unina.it
We performed single-cell RNA-sequencing (scRNA-seq) of 31 breast cancer cell lines, 16 of which from metastatic sites (Supplementary Table 01 and Supplementary Table 02), plus …
G Gambardella, G Viscido, B Tumaini… - Nature …, 2022 - europepmc.org
Cancer cells within a tumour have heterogeneous phenotypes and exhibit dynamic plasticity. How to evaluate such heterogeneity and its impact on outcome and drug response …